MMP2 and esophageal squamous cell carcinoma: Consistently, Western blotting analysis indicated that U0126 treatment dramatically inhibited the expression of MMP-2 and MMP-9 in a dose dependent manner in PAK1-overexpressing ESCC cells (Fig. 5f).